Evidence that A beta 42 is the real culprit in Alzheimer's disease - PubMed (original) (raw)

Editorial

Evidence that A beta 42 is the real culprit in Alzheimer's disease

S G Younkin. Ann Neurol. 1995 Mar.

No abstract available

PubMed Disclaimer

Comment on

• Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome.
  Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y. Iwatsubo T, et al. Ann Neurol. 1995 Mar;37(3):294-9. doi: 10.1002/ana.410370305. Ann Neurol. 1995. PMID: 7695229

Similar articles

• Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
  Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ. Lemere CA, et al. Neurobiol Dis. 1996 Feb;3(1):16-32. doi: 10.1006/nbdi.1996.0003. Neurobiol Dis. 1996. PMID: 9173910
• Apolipoprotein E and Alzheimer's.
  van Bockxmeer FM. van Bockxmeer FM. Nature. 1995 May 25;375(6529):285. doi: 10.1038/375285b0. Nature. 1995. PMID: 7753191 No abstract available.
• Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.
  Hyman BT. Hyman BT. Ann Neurol. 1996 Aug;40(2):135-6. doi: 10.1002/ana.410400202. Ann Neurol. 1996. PMID: 8773592 No abstract available.
• Alzheimer's disease: genetics or environment?
  Mera SL. Mera SL. Br J Biomed Sci. 1996 Jun;53(2):91-2. Br J Biomed Sci. 1996. PMID: 8757683 Review. No abstract available.
• [Views of the pathogenesis in Alzheimer's disease are changing].
  Baumann M, Tienari P, Haltia M. Baumann M, et al. Duodecim. 1999;115(7):767-76. Duodecim. 1999. PMID: 11859510 Review. Finnish. No abstract available.

Cited by

• Phosphorylation modifies the molecular stability of β-amyloid deposits.
  Rezaei-Ghaleh N, Amininasab M, Kumar S, Walter J, Zweckstetter M. Rezaei-Ghaleh N, et al. Nat Commun. 2016 Apr 13;7:11359. doi: 10.1038/ncomms11359. Nat Commun. 2016. PMID: 27072999 Free PMC article.
• REVIEW: Curcumin and Alzheimer's disease.
  Hamaguchi T, Ono K, Yamada M. Hamaguchi T, et al. CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x. CNS Neurosci Ther. 2010. PMID: 20406252 Free PMC article. Review.
• Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme.
  Distefano A, Caruso G, Oliveri V, Bellia F, Sbardella D, Zingale GA, Caraci F, Grasso G. Distefano A, et al. ACS Chem Neurosci. 2022 May 18;13(10):1588-1593. doi: 10.1021/acschemneuro.2c00201. Epub 2022 Apr 26. ACS Chem Neurosci. 2022. PMID: 35471926 Free PMC article.
• Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.
  Martin LJ. Martin LJ. Pharmaceuticals (Basel). 2010;3(4):839-915. doi: 10.3390/ph3040839. Pharmaceuticals (Basel). 2010. PMID: 21258649 Free PMC article.
• Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig.
  Janson J, Eketjäll S, Tunblad K, Jeppsson F, Von Berg S, Niva C, Radesäter AC, Fälting J, Visser SA. Janson J, et al. Pharm Res. 2014 Mar;31(3):670-83. doi: 10.1007/s11095-013-1189-y. Epub 2013 Oct 3. Pharm Res. 2014. PMID: 24092053

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information